David T Rubin

105PUBLICATIONS
230CO-AUTHORS
Medical devicesCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - proteins and peptides (incl. medical proteomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (105)

|Nov 05, 2026
The application of an artificial intelligence-enhanced virtual reality cognitive behavioral therapy tool is feasible and acceptable in patients with inflammatory bowel disease: A multicenter mixed methods pilot study.

|Aug 30, 2026
Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial.

|Aug 28, 2026
Wearable perspiration sensor for continuous inflammation tracking in inflammatory bowel disease.

|Aug 27, 2026
Advancing Equity and Patient Partnership in Clinical Trials for Inflammatory Bowel Disease: A Model for Inclusive Trial Design.

|Jul 28, 2026
Risk of serious infection, myocardial infarction, stroke, and thromboembolic events in patients in the United States with ulcerative colitis treated with tofacitinib compared with biologic treatments.

|Jul 17, 2026
Artificial intelligence assessment of endoscopic severity and extent: A machine learning approach to continuous evaluation of endoscopic inflammation in ulcerative colitis.

Pageof 18

Frequent Collaborators

9 joint publications

Silvio Danese

6 joint publications

Siew C Ng

6 joint publications

Laurent Peyrin-Biroulet

5 joint publications

David K Choi